Antimicrobial resistance pattern of Acinetobacter baumannii clinical isolate in Ethiopia. A systematic review and meta-analysis - Asmare, Zelalem; Tamrat, Ephrem; Erkihun, Mulat; Endalamaw, Kirubel; Alelign, Dagninet; Getie, Molla; Sisay, Assefa; Gashaw, Yalewayker; Reta, Melese Abate (BMC infectious diseases, 2025)
Keywords: Acinetobacter; Acinetobacter baumannii; Acinetobacter baumannii - drug effects; Acinetobacter baumannii - isolation & purification; Acinetobacter Infections - drug therapy; Acinetobacter Infections - epidemiology; Acinetobacter Infections - microbiology; Amikacin; Anti-Bacterial Agents - pharmacology; Antibiotic resistance; Antibiotics; Antimicrobial agents; Antimicrobial resistance; Bacterial diseases; Bacterial infections; Bias; Carbapenem resistance; Carbapenems; Cefotaxime; Clinical isolates; Clinical medicine; Drug resistance; Drug resistance in microorganisms; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethiopia; Ethiopia - epidemiology; Global health; Health risks; Heterogeneity; High resistance; Hospitals; Humans; Medical research; Medical Subject Headings-MeSH; Medicine, Experimental; Meta-analysis; Microbial Sensitivity Tests; Multi-drug resistance; Multidrug resistance; Pathogens; Physiological aspects; Public health; Search engines; Sepsis; Statistical analysis; Subgroups; Surgical site infections; Systematic Review; Urinary tract; Urinary tract diseases; Urinary tract infections; Urogenital system; β Lactamase; Ethiopia; United States--US; Acinetobacter; Multi-drug resistance; Carbapenem resistance; Ethiopia